The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million ...

AstraZeneca PLC ADR closed 14.68% short of its 52-week high of $87.68, which the company achieved on August 30th.

Astrazeneca is too big and complex to base its chief executive’s pay packet on the rest of the FTSE index, according to the ...

AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn ...

AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...

A class action lawsuit was filed against AstraZeneca Plc (AZN) by Levi & Korsinsky on December 23, 2024. The plaintiffs ...

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

AstraZeneca is expecting Phase III trial data for seven new medicines in 2025, its CEO said as he confirmed the company’s ...

UBS Group upgraded shares of AstraZeneca (NASDAQ:AZN – Free Report) from a neutral rating to a buy rating in a research note ...

AstraZeneca (AZN) has reported positive results from an analysis of its NIAGARA Phase 3 study of Imfinzi in the treatment of ...

Net Sales at Rs 440.29 crore in December 2024 up 43.98% from Rs. 305.79 crore in December 2023. Quarterly Net Profit at Rs.